Protective effect of Thymus munbyanus aqueous extract against 2,4-dichlorophenoxyacetic acid-induced nephrotoxicity in Wistar rats

Toxic ties: Unraveling the complex relationship between endocrine disrupting chemicals and chronic kidney disease

Environmental pollution is inherently linked to several metabolic diseases and high mortality. The kidney is more susceptible to environmental pollutants compared to other organs as it is involved in concentrating and filtering most of these toxins. Few epidemiological studies revealed the intrinsic relationship between exposure to Endocrine Disrupting Chemicals (EDCs) and CKD development. Though EDCs have the potential to cause severe pathologies, the specific molecular mechanisms by which they accelerate the progression of CKD remain elusive. In particular, our understanding of how pollutants affect the progression of chronic kidney disease (CKD) through the gut-kidney axis is currently limited. EDCs modulate the composition and function of the gut microbial community and favor the colonization of harmful gut pathogens. This alteration leads to an overproduction of uremic toxin and membrane vesicles. These vesicles carry several inflammatory molecules that exacerbate inflammation and renal tissue damage and aggravate the progression of CKD. Several experimental studies have revealed potential pathways by which uremic toxin further aggravates CKD. These include the induction of membrane vesicle production in host cells, which can trigger inflammatory pathways and insulin resistance. Reciprocally, CKD can also modulate gut bacterial composition that might further aggravate CKD condition. Thus, EDCs pose a significant threat to kidney health and the global CKD burden. Understanding this complicated issue necessitates multidisciplinary initiatives such as strict environmental controls, public awareness, and the development of novel therapeutic strategies targeting EDCs.

Lipid peroxidation and changes in major antioxidant markers in copper quinolate fungicide-exposed rats

The present study investigated the toxic effects of sub-chronic exposure to copper quinolate (CuQ) fungicide on liver and kidney function. Twenty-four adult male Wistar rats were equally divided into a control group, and three treated groups received, respectively, by oral gavage, three increasing doses of CuQ: 47; 67.1; and 94 mg/kg b.w corresponding, respectively, LD50/100, LD50/70, and LD50/50 daily for 8 weeks. CuQ resulted in a significant increase in the serum enzymatic activity of aspartate aminotransferase (AST), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), and the serum levels of urea, creatinine, uric acid, and malondialdehyde, along with a marked decrease in alanine aminotransferase (ALT) activity, and the contents of total protein and albumin compared to those of the control group. Furthermore, glutathione content and the enzymatic activity of superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), and glutathione peroxidase (GPx) decreased significantly in a dose-dependent manner with respect to CuQ. The adverse effects of CuO were supported by the histopathological evaluations of liver and kidney tissues. Conclusively, sub-chronic CuQ exposure was shown to induce kidney and liver oxidative damage and dysfunction.

The antioxidant study proprieties of Thymus munbyanus aqueous extract and its beneficial effect on 2, 4-Dichlorophenoxyacetic acid -induced hepatic oxidative stress in albino Wistar rats

Herein, we investigated the antioxidant and hepatoprotective effects of thyme (Thymus munbyanus: AETM) on 2,4-dichlorophenoxyacetic acid (2,4 -D) - induced liver oxidative damage in rats. The phytochemical study of AETM revealed potent antioxidant properties owed to its richness in phenolic compounds including flavonoids, tannins, and phenolic acids. Further, in vivo animal study was conducted on 24 Wistar rats divided equally into control group and three treated groups, receiving orally AETM (10 ml/kg body weight (b.w), 2,4-D (5 mg/kg (b.w) and AETM + 2,4 - D (combined treatment) for 30 consecutive days. The results showed a significant increase in the enzymatic activity of transaminases (AST, ALT), alkaline phosphatase (ALP), gamma-glutamyltransferase (γ-GT), lactate dehydrogenase (LDH), and the levels of malondialdehyde (MDA) and carbonyl proteins (CPO), along with a significant decrease in plasma total protein, albumin, hepatic glutathione (GSH) contents, and the enzymatic activity of the hepatic antioxidant markers (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione- S- transferase (GST)) in 2,4- D treatment compared with control. Moreover, no significant changes in these parameters were noticed in AETM treated animals as compared to control, and hence the combined treatment (AETM + 2,4- D) showed a marked enhancement in the above altered hepatic functional and antioxidant parameters and liver histopathology. In conclusion, AETM, owing to its richness with phenolic compounds proved to be an efficient antioxidant against 2,4-D - induced liver oxidative damage, and hence complementary studies would be needed to appear the use of these compounds as supplements in treating liver impairment.